Literature DB >> 6873972

Seeding efficiency, plating efficiency, and population doublings of human skin fibroblastlike cells: results of replicate testing.

R Vracko, B H McFarland, R E Pecoraro.   

Abstract

Using skin fibroblastlike cells from 10 healthy volunteers, 12 to 54 yr old, we measured, in replicates, seeding efficiency (SE), plating efficiency (PE), and population doublings (PD) during 2 wk of growth and the cumulative replicative life span (CRLS). We determined the effects of donor age and of in vitro cell age on the test results and test precision. We found that (a) On the average, SE was 82% +/- 24 SD, PE was 12% +/- 9 SD, PD was 7.3 doublings +/- 2.5 SD, and CRLS was 31.1 doublings +/- 9.6 SD. (b) Plating efficiency and PD correlated well with each other and with CRLS whereas SE did not correlate with PE, PD, or CRLS. (c) Plating efficiency and PD were affected negatively by increasing passage levels and by donor ages, but the influence of age was evident only for cells from early passages. Seeding efficiency was not affected by either of the two variables. (d) Variations in PD from early passages explained half of the donor-to-donor variation in CRLS whereas PD from later passages had little or no predictive power. (e) Of the two short term tests, PD had better precision than PE. For replicate runs with cells from early passages the coefficient of variation was 44% for PE and 15% for PD. The results show that PD for cells from early passages in mass culture give rapid results, which express the in vitro replicating potential of cells from different donors with greater precision than do measurements of CRLS.

Entities:  

Mesh:

Year:  1983        PMID: 6873972     DOI: 10.1007/bf02619598

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  23 in total

1.  Growth of human embryonic fibroblasts at clonal density: concordance with results from mass cultures.

Authors:  J R Smith; K I Braunschweiger
Journal:  J Cell Physiol       Date:  1979-03       Impact factor: 6.384

2.  Defects in the cell cycle of fibroblasts obtained from patients with cystic fibrosis.

Authors:  J C Houck; F L Cheng
Journal:  Proc Soc Exp Biol Med       Date:  1974-10

3.  Restricted replicative life-span of diabetic fibroblasts in vitro: its relation to microangiopathy.

Authors:  R Vracko; E P Benditt
Journal:  Fed Proc       Date:  1975-01

4.  Intraclonal variation in proliferative potential of human diploid fibroblasts: stochastic mechanism for cellular aging.

Authors:  J R Smith; R G Whitney
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

5.  Age affect and replicative life-span of fibroblasts of diabetic, prediabetic, and normal donors: another look at the data.

Authors:  R E Gleason; S Goldstein
Journal:  Science       Date:  1978-12-15       Impact factor: 47.728

6.  Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors.

Authors:  S Goldstein; E J Moerman; J S Soeldner; R E Gleason; D M Barnett
Journal:  Science       Date:  1978-02-17       Impact factor: 47.728

7.  Diabetes mellitus and genetic prediabetes. Decreased replicative capacity of cultured skin fibroblasts.

Authors:  S Goldstein; E J Moerman; J S Soeldner; R E Gleason; D M Barnett
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

8.  Premature senescence in cultured skin fibroblasts from subjects with cystic fibrosis.

Authors:  B L Shapiro; L F Lam; L H Fast
Journal:  Science       Date:  1979-03-23       Impact factor: 47.728

9.  Diabetes and cell growth--lack of differences in growth characteristics of fibroblasts from diabetic and nondiabetic Pima Indians.

Authors:  B V Howard; R M Fields; D M Mott; P J Savage; M Nagulesparan; P H Bennett
Journal:  Diabetes       Date:  1980-02       Impact factor: 9.461

10.  Colony size distributions as a measure of in vivo and in vitro aging.

Authors:  J R Smith; O M Pereira-Smith; E L Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.